Faruqi & Faruqi, LLP is Investigating Emergent BioSolutions (EBS) on Behalf of its Shareholders

New York, New York--(Newsfile Corp. - June 23, 2021) - Faruqi & Faruqi, LLP, a leading minority and Woman-owned national securities law firm, is investigating potential misconduct at Emergent BioSolutions Inc. ("Emergent BioSolutions" or the "Company") (NYSE: EBS).

The investigation focuses on whether the Company's Board of Directors and/or officers breached their fiduciary duties.

Request more information now by clicking here: www.faruqilaw.com/EBS. There is no cost or obligation to you.

Take Action

If you currently own Emergent BioSolutions stock, have continuously owned Emergent BioSolutions stock and would like to discuss your legal rights, please visit www.faruqilaw.com/EBS. You can also contact us by calling Nina Varindani or Christopher M. Lash toll free at (215) 277-5770 (Ext. 1413) or by sending an e-mail to nvarindani@faruqilaw.com or clash@faruqilaw.com. Faruqi & Faruqi, LLP also encourages anyone with information regarding the Company's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Delaware, Pennsylvania, California and Georgia.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

FARUQI & FARUQI, LLP
685 3^rd Avenue, 26^th Floor
New York, NY 11237
Attn: Nina Varindani
nvarindani@faruqilaw.com
Telephone: (212) 983-9330

FARUQI & FARUQI, LLP
1617 JFK Boulevard, Suite 1550
Philadelphia, PA 19103
Attn: Christopher M. Lash
clash@faruqilaw.com
Telephone: (215) 277-5770

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/88371